ReviewThe Journal of antibiotics2019

Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics.

Ken-Ichi KimuraPubMed ↗Publisher ↗

No numbers read from the abstract.